We can't miss this vital chance for national prostate-cancer screening, says Rishi Sunak

Rishi Sunak is renewing calls for a 'vital' national prostate cancer-screening programme as he prepares to attend a testing ...

RISHI SUNAK: An early test helped save my friend David Cameron's life. We must help other men, too

The Government now has the chance to save countless lives by introducing a targeted screening programme for prostate cancer , the most common cancer among British men.
MedPage Today

Tranexamic Acid Reduces Major Bleeding in Urologic Surgery

Use of tranexamic acid (TXA) reduced the risk of major bleeding in patients undergoing urologic surgery, results from the randomized POISE-3 trial showed. Among more than 1,100 patients, 6.1% of those ...
Open Access Government

UK’s first remote robotic surgery performed by King’s College London surgeon

King’s College London surgeon performs the UK’s first remote robotic surgery, pioneering telesurgery and transforming patient care ...
ahajournals.org

Abstract 4352126: Accelerated Coronary Atherosclerosis Following Relugolix Versus Leuprolide Androgen Deprivation Therapy in Men with Prostate Cancer (REVELUTION): An Open ...

Methods: This prospective three-arm trial enrolled men with treatment-naïve, localized PCa pursuing pelvic radiotherapy (RT) alone or with concomitant ≥ 6 months ADT. Patients receiving ADT were ...

Julian Garrett diagnosed with prostate cancer, won't seek reelection

State Sen. Julian Garrett has been diagnosed with prostate cancer and will not seek reelection to his seat representing Warren County.

Remote robot surgery removes cancer 1,500 miles away

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.
Hospital Healthcare Europe

Baseline PSA levels linked to long-term prostate cancer risk in population study

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.
ascopubs.org

Triplet therapy with ADT, darolutamide, and biweekly docetaxel for high-risk metastatic castration-sensitive prostate cancer (TRIC): An open-label, single-arm phase II clinical ...

SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose optimization study for a single dose of 153Sm-DOTMP to treat metastatic bone pain. This is an ASCO Meeting Abstract from the 2026 ASCO ...
ascopubs.org

A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer ...

CARPET trial: A phase II trial evaluating trastuzumab deruxtecan in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium ...
UroToday

ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical ...

Darolutamide is an androgen receptor inhibitor (ARI) with low blood-brain barrier penetration, potentially resulting in low reactive testosterone increases and less feminizing adverse events (AEs). In ...
openaccessgovernment

Microplastics found in 90% of prostate cancer tumours

New research from NYU Langone Health detects microplastics in 9 out of 10 prostate cancer tumours, with levels 2.5× higher than healthy tissue A new study from NYU Langone Health has detected ...